IRIS UniCatt

Galli, Eugenio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.173
NA - Nord America 870
AS - Asia 658
SA - Sud America 172
AF - Africa 18
Totale 2.891
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 846
SG - Singapore 268
IT - Italia 241
DE - Germania 219
CN - Cina 171
SE - Svezia 160
BR - Brasile 154
PL - Polonia 139
FI - Finlandia 121
FR - Francia 93
IN - India 70
IE - Irlanda 41
KR - Corea 38
ID - Indonesia 36
GB - Regno Unito 33
CZ - Repubblica Ceca 22
RU - Federazione Russa 22
AT - Austria 19
CA - Canada 18
BE - Belgio 13
NL - Olanda 11
CI - Costa d'Avorio 9
HK - Hong Kong 9
TR - Turchia 9
CO - Colombia 8
ES - Italia 7
LT - Lituania 7
UA - Ucraina 7
UZ - Uzbekistan 7
VN - Vietnam 6
BD - Bangladesh 5
SA - Arabia Saudita 5
IL - Israele 4
IQ - Iraq 4
ZA - Sudafrica 4
AR - Argentina 3
AZ - Azerbaigian 3
BY - Bielorussia 3
IR - Iran 3
JP - Giappone 3
KE - Kenya 3
KG - Kirghizistan 3
MX - Messico 3
RO - Romania 3
VE - Venezuela 3
BO - Bolivia 2
HU - Ungheria 2
JO - Giordania 2
LU - Lussemburgo 2
LV - Lettonia 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
EC - Ecuador 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 2.891
Salva come PNG Salva come JPEG
Città #
Singapore 193
Warsaw 136
Chandler 129
Munich 128
Ashburn 87
Helsinki 79
Rome 64
Hyderabad 57
Milan 52
Chicago 39
Dublin 39
Seoul 38
Hefei 36
Jakarta 36
The Dalles 36
Florence 35
New York 33
Fairfield 31
Frankfurt am Main 30
Los Angeles 24
Lappeenranta 17
Santa Clara 17
Turku 17
Seattle 16
Brno 15
Moscow 15
Bremen 14
Nuremberg 14
Wilmington 14
Brussels 13
Düsseldorf 13
Marseille 13
Woodbridge 13
Princeton 12
Boston 11
Lauterbourg 11
London 11
San Mateo 10
Vienna 10
Abidjan 9
Beijing 9
Brooklyn 9
Houston 9
Redmond 9
Belo Horizonte 8
Falls Church 8
Hong Kong 8
Toronto 8
Paris 7
Tashkent 7
Cambridge 6
Cattolica 6
Falkenstein 5
Montreal 5
Portsmouth 5
Pune 5
Tampa 5
Bexley 4
Bogotá 4
Brdo 4
Buffalo 4
Campinas 4
Catania 4
Charlotte 4
Columbus 4
Curitiba 4
Dong Ket 4
Governador Valadares 4
Guangzhou 4
Jacksonville 4
São Paulo 4
Washington 4
Amsterdam 3
Ann Arbor 3
Atlanta 3
Bishkek 3
Cagliari 3
Caxias do Sul 3
Hortolândia 3
Johannesburg 3
La Paz 3
Lancaster 3
Nanjing 3
North Bergen 3
Norwalk 3
Redwood City 3
Rio de Janeiro 3
Riyadh 3
Salvador 3
San Diego 3
Shanghai 3
St Petersburg 3
Tokyo 3
Turin 3
Afragola 2
Amman 2
Ankara 2
Araras 2
Arezzo 2
Augusta 2
Totale 1.824
Salva come PNG Salva come JPEG
Nome #
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients 248
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 224
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 171
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 95
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 89
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 85
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 84
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 79
Burkitt lymphoma as fourth neoplasia in a patient affected by cowden syndrome with a novel PTEN germline pathogenic variant 78
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 74
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation 72
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 71
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 70
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 68
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 60
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 57
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 56
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 56
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 56
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 54
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 53
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 53
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 51
CAR-T treatment is safe and effective in adult patients with Down syndrome and B-cell acute lymphoblastic leukemia (B-ALL) 51
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 48
G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma 44
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 41
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 40
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 40
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 39
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 39
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 39
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 38
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation 37
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 35
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 34
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 34
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 32
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study 32
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia 31
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma 31
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant 31
Spontaneous resolution of “therapy-related myelodysplasia” occurred after treatment with CAR-T cells: All that glitters is not gold 30
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center 29
Impact of Pretransplant Salvage Therapies on Outcome of Hodgkin Lymphoma Patients Performing Allogeneic Transplant 29
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 26
Coagulopathy in CAR-T: Critical concern or mere blip? 26
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT 26
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma 23
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 18
Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)? 15
Prognostic factors in hodgkin lymphoma 14
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 13
VEGF as a Relapse Marker and an Intensity of Disease Marker in Patients Affected by POEMS Syndrome Treated With Autologous Peripheral Blood Stem Cell Transplantation 9
Totale 2.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.212
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.212
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 0 0 9
2020/202195 5 12 5 6 18 6 9 2 7 7 12 6
2021/2022135 9 5 5 5 14 8 3 14 6 6 27 33
2022/2023450 74 51 17 68 30 54 35 27 48 21 23 2
2023/2024412 10 72 28 42 6 52 30 38 7 34 34 59
2024/20251.677 40 30 79 172 119 96 124 79 190 172 418 158
Totale 2.978